Clec12a | List of Frontiers open access articles

Original Research

Published on 21 Jun 2021

The Inhibitory Receptor CLEC12A Regulates PI3K-Akt Signaling to Inhibit Neutrophil Activation and Cytokine Release

in Molecular Innate Immunity

Guillaume Paré
Julien Vitry
Michael L. Merchant
Myriam Vaillancourt
Andréa Murru
Yunyun Shen
Sabine Elowe
Mireille H. Lahoud
Paul H. Naccache
Kenneth R. McLeish

Frontiers in Immunology

doi 10.3389/fimmu.2021.650808

10,433 views
28 citations

Original Research

Published on 08 Dec 2023

CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation

in Breast Cancer

Ranodeep Chatterjee
Aditya Shukla
Kausiki Chakrabarti
Urmi Chatterji

Frontiers in Oncology

doi 10.3389/fonc.2023.1242432

5,980 views
9 citations

Mini Review

Published on 20 Aug 2018

The Role of Inhibitory Receptors in Monosodium Urate Crystal-Induced Inflammation

in Inflammation

Maria J. Fernandes
Paul H. Naccache

Frontiers in Immunology

doi 10.3389/fimmu.2018.01883

8,171 views
17 citations

Original Research

Published on 27 Mar 2025

CLEC12A-directed immunocytokine with target cell–restricted IL-15 activity for treatment of acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Boris Klimovich
Leonard Anton
Jinwon Jung
Yangmi Lim
Bora Lee
Jonghwa Won
Latifa Zekri
Anna Chashchina
Martin Pflügler
Jonas S. Heitmann

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561823

3,720 views

Original Research

Published on 13 May 2020

Characterization of the Porcine CLEC12A and Analysis of Its Expression on Blood Dendritic Cell Subsets

in Comparative Immunology

Belén Álvarez
Elvira Nieto-Pelegrín
Paloma Martínez de la Riva
Daisuke Toki
Teresa Poderoso
Concepción Revilla
Hirohide Uenishi
Angel Ezquerra
Javier Domínguez

Frontiers in Immunology

doi 10.3389/fimmu.2020.00863

5,603 views
8 citations

Mini Review

Published on 18 Feb 2020

C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity

in Antigen Presenting Cell Biology

Marion Drouin
Javier Saenz
Elise Chiffoleau

Frontiers in Immunology

doi 10.3389/fimmu.2020.00251

33,085 views
120 citations

Review

Published on 09 Aug 2023

Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy

in NK and Innate Lymphoid Cell Biology

Minchuan Zhang
Kong-Peng Lam
Shengli Xu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1207276

28,889 views
51 citations

Correction

Published on 14 Mar 2024

Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation

in Breast Cancer

Ranodeep Chatterjee
Aditya Shukla
Kausiki Chakrabarti
Urmi Chatterji

Frontiers in Oncology

doi 10.3389/fonc.2024.1393626

1,758 views

Articles

The Inhibitory Receptor CLEC12A Regulates PI3K-Akt Signaling to Inhibit Neutrophil Activation and Cytokine Release

CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation

The Role of Inhibitory Receptors in Monosodium Urate Crystal-Induced Inflammation

CLEC12A-directed immunocytokine with target cell–restricted IL-15 activity for treatment of acute myeloid leukemia

Characterization of the Porcine CLEC12A and Analysis of Its Expression on Blood Dendritic Cell Subsets

C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity

Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy

Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation